You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
Quad Pill
Gilead and Tibotec To Develop New Combo Pill 7-5-2011 Gilead Quad Pill Works as Well As Atripla 4-4-2011 Gilead Will Extend Phase 3 Elvitegravir Trial to 96 Weeks 1-18-2011
Elvitegravir "Quad" Single-tablet Regimen Shows Continued HIV Suppression at 48 Weeks 9-14-2010
Gilead's Quad Pill Matches Atripla, New Booster Cobicistat (GS 9350) Looks Good with Atazanavir (Reyataz) 2-19-2010
